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Prevention of post-operative
nausea and vomiting with
honey as a pre-operative oral
carbohydrate: A randomised
controlled pilot trial
Abstract
Background: Post-operative nausea and vomiting (PONV) is the secondmost common post-operative complication. Prolonged pre-operative fasting
is common in Australia despite guidelines recommending reduced fasting
to improve patient outcomes, such as PONV. Commercially prepared preoperative oral carbohydrate (OC) drinks may be used to reduce fasting time.
In this study commercial products were replaced with honey, an inexpensive
and common food item.
Design: Partially blinded, four parallel arms randomised controlled noninferiority trial compared pre-operative OC loading with overnight fasting.
Methods: Adult elective laparoscopic cholecystectomy and thyroidectomy
patients having two or more risk factors for PONV were allocated into
intervention and control groups by simple randomisation. The intervention
group ingested 60g of honey in 100 ml of water at least two hours before
surgery as pre-operative OC loading to reduce PONV. Participants and
assessors to the group assignment were blinded to the study outcomes. Early
PONV (0–6 hours) was measured with Rhodes index of nausea, vomiting and
retching (R-INVR) and a numeric rating scale (NRS).
Results: The four groups (N = 142) were control and intervention groups of
thyroidectomy patients (n = 72: C = 37, I = 35), and control and intervention
groups of laparoscopic cholecystectomy patients (n = 70: C = 37, I = 33) and
had similar distributions of variables. The estimated effect size was 140 with
a 95 percent confidence interval. The PONV incidence (Pearson χ2 = 4.54;
df = 1; p = 0.03) and severity were significantly lower in the laparoscopic
cholecystectomy intervention group (R-INVR: Mann–Whitney U = 446.5; p =
0.01; NRS: Mann–Whitney U = 444.5; p = 0.01) and results were not conclusive
in the thyroidectomy group (NRS: Mann–Whitney U = 629.5; p = 0.95; R-INVR:
Mann–Whitney U = 629.5; p = 0.76).
Conclusion: Honey could be recommended as an inexpensive pre-operative
OC to reduce PONV in adult patients receiving general anaesthesia.
Keywords: pre-operative, carbohydrate loading, honey, post-operative nausea
and vomiting, prevention, randomised controlled trial
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Introduction
Overnight fasting of patients before
surgery (no oral intake from midnight
until surgery) is an outdated and
harmful practice; however, it remains
common in Australia. The fasting
period is frequently prolonged –
greater than 12 hours and up to
24 hours. Guidelines recommend
reduced fasting and early postoperative oral intake to improve
patient outcomes such as postoperative nausea and vomiting
(PONV) and glycaemic balance.
One strategy to reduce the fasting
period is providing patients with
oral carbohydrate (OC) drinks up to
two hours before surgery. However,
evidence-based guidelines on
pre-operative fasting are poorly
implemented and research is not
being translated into reduced fasting
times.1,2
Despite the improvement in
anaesthesiology and surgical
methods, PONV is the secondmost common post-operative
complication, experienced by
approximately one third of all
perioperative patients. 3–5 The
aetiology and pathophysiology
of PONV is multidimensional and
not fully understood. The nausea
and vomiting centre, located in
the medulla oblongata of the
brain, is thought to respond
to chemoreceptor inputs from
blood circulation, toxins or
other stimulants received from
the gastrointestinal tract, and
other inputs from the cerebral
cortex, thalamus and vestibular
region. 5 PONV is considered to be
a consequence of physiological
stress, prolonged fasting time
and anaesthetic agents.6,7
Increased length of hospital stay
and subsequent increased cost,
discomfort, anxiety, incisional
tension and pain can occur due to
PONV.8–10

e-22

Recommendations for the prevention
of PONV include reduced preoperative fasting, early postoperative oral intake, determination
of the risk groups and prophylactic
interventions for those at high risk
of developing PONV.1,7 However, the
best way to manage PONV has not
yet been determined, although 5-HT3
receptor antagonists, glucocorticoids
or a combination of these are used
with limited efficacy.1,11,12 Many
studies have investigated the best
practice for pharmacological PONV
management; however, many had
suboptimal methodology resulting in
a weak to moderate level of evidence
for prevention.13–15 The recommended
approach for managing PONV is
to determine patients at higher
risk of developing PONV and
focus on prevention for this
population rather than the current
practice of polypharmacological
interventions for all surgery patients.
Polypharmacological intervention for
PONV poses a risk of adverse effects,
such as drowsiness and hypotension,
and increases the cost of care.
Non-pharmacological interventions
for PONV include reducing the
fasting time and pre-operative OC
loading.7,15,16
Current recommendations regarding
non-pharmacological interventions
for managing PONV include oral
pre-operative carbohydrate.6,17,18 The
evidence remains moderate as PONV
is a multifaceted issue and previous
studies lack inclusion of all relevant
variables. For instance, some reports
did not present an anaesthesia
protocol, some were unclear
regarding the medical management
of PONV and very few included data
regarding PONV risk factors; thus,
making comparisons to results in
future studies is difficult.6,19,20 We
have not found any studies that
used honey as an oral pre-operative
carbohydrate for PONV or any other
type of nausea prevention.

The evidence for the effectiveness of
pre-operative OC loading in reducing
PONV has not been conclusive;
however, it was recommended as
a simple and safe intervention to
reduce fasting time (gastric emptying
time for clear fluids was determined
between 60 to 90 min). 21–24 OC loading
is described as ingestion of 400–800
ml of OC the night before surgery
and 200–400 ml up to two hours
before elective surgery.1,6
Studies indicate that reducing
pre-operative fasting time
improves patients’ comfort, insulin
resistance and stress responses
in the post-operative period. 21,23
Moreover, the pre-operative OC
loading improved post-operative
insulin resistance and return of
bowel function,6,17 and did not
increase the risk of aspiration. 22,25,26
The recommendations from
anaesthesiology professionals
resulted in commercial pre-operative
drinks emerging in the market and
being promoted to health care
institutions with an additional cost.
The content of these commercial
pre-operative drinks varies but is
usually a hypo-osmolar solution
including around 50 grams of
complex glucose, sometimes with
vitamins and minerals. 22,27,28 The
economic and environmental
impact of manufacturing, packaging,
storing and distributing is assumed
to be a significant consideration
when developing a commercial OC
preparation, whereas using honey,
a common pantry item that can be
ingested by patients as preferred,
avoids these impacts. Honey has
been used for gastric mucosal
protection and healing, and its
consumption has been shown to
be just as effective as sucralfate or
allopurinol 29–31 in reducing glycated
hemoglobin, LDL cholesterol, and
fasting triglycerides. 32
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Previous studies measured PONV as
a gastric complication, as described
in the design section. Therefore, the
current study was planned as a pilot
superiority randomised controlled
trial to support or refute our
hypothesis that a natural nutrient
source, honey, would be beneficial to
prevent or reduce PONV.

Hypotheses

Pre-operative OC has been beneficial
for reducing PONV in a number of
studies6,33,34 and was recommended
in the Enhanced Recovery After
Surgery (ERAS) guidelines.6 As a
natural carbohydrate source, honey
has an antioxidant effect with
tocopherol, ascorbic acid, flavonoids
and other phenolic-enzyme
compounds in its structure. 35–37 To
date, there are no published studies
investigating the effect of honey
consumption on PONV or any other
type of nausea, to our knowledge.

Hypothesis 2: Pre-operative oral
intake of 60 g of honey in 100 ml
of water is associated with a lower
incidence and severity of early
PONV for thyroidectomy patients,
compared with standard preoperative overnight fasting.

Perioperative nurses are patient
advocates for improving surgical
outcomes and reducing the cost
of health care. This study presents
evidence and recommendations
for reducing the pre-operative
fasting period by replacing
commercial carbohydrate products
with a common food item,
informing practice regarding nonpharmacological interventions
and introducing a new method for
managing PONV.

Aim
The aim of this randomised control
trial (RCT) was to evaluate whether
pre-operative oral honey and water
intake is associated with a lower
incidence and severity of PONV in
adult participants, compared to
overnight fasting.

Hypothesis 1: Pre-operative oral
intake of 60 g of honey in 100 ml
of water is associated with a lower
incidence and severity of early PONV
for laparoscopic cholecystectomy
patients, compared with standard
pre-operative overnight fasting.

Methods
Study design
The study was designed as a singlecentred, open-label randomised
control non-inferiority trial with a
1:1 allocation ratio. The impact on
PONV incidence and severity of oral
administration of honey in water as
oral carbohydrate loading to reduce
fasting time was compared with
overnight fasting .

PONV risk factors and the
participants selection
The factors that affect incidence of
PONV are: female gender, history
of PONV or motion sickness, not
smoking, younger age, general
anaesthesia, use of volatile
anaesthetics and nitrous oxide,
use of post-operative opioids,
longer duration of anaesthesia and
type of surgery (cholecystectomy,
laparoscopic, gynaecological).1,5
We considered Koivuranta’s five
risk factors (female, age <50, nonsmoking, duration of anaesthesia
>60 min, history of PONV or motion
sickness 38) as they were indicated to
be superior to Apfel’s risk factors 39
(female, non-smoking, history of
PONV or motion sickness, use of
post-operative opioids 5). To obtain
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more robust results in smaller
samples, we aimed to include
patients with two or more of
Koivuranta’s risk factors.
Elective laparoscopic
cholecystectomy and thyroidectomy
surgeries were targeted, to obtain
consistent results with previous
studies24 and to reach a robust
sample size for comparison, as these
surgeries were frequent in the study
setting.
Patients aged 18 to 79, having two
or more Koivuranta risk factors for
PONV 38 were approached between
May 2017 and January 2018. Patients
with diabetes, oral restrictions other
than fasting, or pollen allergy were
excluded (Figure 1).

Intervention (description
of study procedures and
methods)
The intervention in this study was
the oral intake of a honey and
water mixture as a pre-operative
carbohydrate source. We compared
the impact on PONV incidence
and severity of oral honey intake
with overnight fasting. Previous
studies used 50 g (200 kilocalories)
of carbohydrate in 400 ml of water
two hours pre-operatively. The
anaesthesiology department where
the study was conducted limited the
oral fluid to 100 ml. Therefore, our
intervention was 60 grams of honey
(200 kilocalories approx.) in 100 ml
of spring water at room temperature.
The mixture was ingested by
participants up to two hours preoperatively.
The honey used in the study was
purchased from a single producer,
collected in the same season and in
the same region for consistency of
chemical and glycaemic properties.
The honey samples were tested for
quality and confirmed to meet the
quality standards of international
consumable honey.40
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Institutional permission was obtained.

Ethical committee and institutional approvals were obtained.

The randomised numbers were obtained from the program.

All elective laparoscopic cholecystectomy and thyroidectomy patients who were at the institution for the
anaesthesia examination in between 16:00 and 18:00 each day were approached and invited to participate
in the study

Each eligible participant signed the informed consent form. A consecutive registry number was given which
determined the allocation to the control or intervention groups by the match of the randomised numbers
list. Initial pre-operative data were collected.

Laparoscopic cholecystectomy

Control
(standard overnight fasting)

Thyroidectomy

Intervention

Control
(standard overnight fasting)

Subjects in the intervention
groups ingested the honey and
water mix two hours prior to their
anaesthesia induction.*

All subjects were observed by nurses in the Post Anaesthesia Care Unit (PACU) and the wards for the first
six post-operative hours as part of routine vital observations protocol.

The participants were informed regarding the outcomes of the study.

Figure 1: Research process diagram
*Subjects whose surgery was planned as second, third and fourth cases of the day were given the honey and water mixture an
estimated two hours before surgery.

e-24
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The primary investigator prepared
a food-grade jar with 60 g of honey,
marked each jar to the top-up point
of 100 ml for water to be added
and mixed before consuming.
The hospital where the study was
conducted admits perioperative
patients at 7.00 am, and the first
case of each operating room
commences at 8.00 am. Therefore,
the first patients of each operating
room list were instructed to
consume the mixture at 6.00 am
before coming to the hospital and
two hours before the anaesthesia
induction. The primary investigator
phoned the participants a day
before the operation and repeated
the instructions. Confirmation of
drinking the mixture was sought on
hospital admission by the primary
investigator. The same investigator
observed the participants’ intake at
the hospital for the remainder of the
cases on each operating room list
of the day from 8.00 am onwards.
Patients who did not follow these
instructions were excluded from the
study.
All participants received the same
protocol (as follows) for a general
inhalation (inh.) and intravenous
(IV) anaesthesia: propofol 1-1.5
mg/kg (IV), midazolam 0.03-0.05
mg/kg (IV), fentanyl 0.5-1 mg/
kg (IV), rocuronium bromide 0.30.6 mg/kg (inh.), sevoflurane %23/L (inh.), prophylactic antibiotic 1
g (IV), paracetamol 1 g (IV), atropine
sulphate 1 mg (IV), neostigmine
methyl sulphate 2 mg (IV), famotidine
20 mg (IV).

Outcomes
There were two primary outcomes
for this study:
1.

the incidence of PONV per group
over the early post-operative
period (0–6 hours)

2.

the severity of PONV per group
over the early post-operative
period (0–6 hours).

Data collection
The data collection form consisted of
three sections:
1.

participant characteristics –
age, gender, education, height,
weight, BMI, general health
condition and planned type of
surgery

2.

PONV risk factors – gender, age,
smoking status, anaesthesia
medications, duration of
anaesthesia and history of PONV
or motion sickness 5,38

3.

post-operative complications –
pain, bleeding, antiemetic use,
PONV incidence and severity
(measured by the Rhodes index
of nausea, vomiting and retching
(R-INVR) and the numeric rating
scale (NRS) at each routine postoperative assessment for the
first six hours post-operatively.

The first part of the data collection
form was completed by the primary
investigator during the pre-operative
anaesthesia examination of patients.
Data for the second section was
pulled from the institutional patient
data, and data for the third section
was collected by nurses who were
trained by the primary investigator
prior to data collection. The nurses
in the Post Anaesthesia Care
Unit (PACU) and general surgery
departments collected the postoperative data by observation
and patient reporting in the first
post-operative hour, and by patient
reporting in the next five postoperative hours.
The R-INVR and NRS were used for
PONV measurement along with
routine post-operative observations
which were conducted, according to
hospital protocol, every 15 minutes
in the first hour, every 30 minutes
in the second hour and hourly
thereafter. PONV incidence and
severity were measured by R-INVR
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scores (eight items, 0–4 points;
total of 0–32 points) and NRS (0 to
10 patient expression) in the early
post-operative period, zero to six
hours after surgery. The highest
recorded scores of PONV within the
observation period were used for the
analysis; the intervention group was
compared to the control group for
each type of surgery.

Description of instruments,
including measurement
reliability and validity
evidence
The R-INR and NRS are validated
scales and have been used in
previous studies of PONV. The
R-INVR was developed by Rhodes
and McDaniel in 1999, validated for
PONV in adult patients by Kim et al.
in 2007 and Genc and Tan proved
language validity of the scale in 2010.
It is widely used in the literature for
PONV. 39,41–44 Responses are recorded
using a scale ranging from ‘0’ for
no discomfort to ‘4’ for the highest
discomfort, with a total of 32 points
for eight scale items. The internal
consistency coefficient of the scale
was 0.91; sub-dimensions alpha
internal consistency coefficients
were 0.81 and 0.89 for ‘symptom
development’ and ‘symptom
discomfort’ respectively in this study.
The NRS is a widely used tool
and has been used in several
studies to measure PONV in similar
populations, including adult
laparoscopic cholecystectomy
patients. Patients were asked by
nurses to rate their discomfort,
nausea, vomiting/retching and
pain on an NRS ranging from ‘0’
for no complaints to 10 for worst
imaginable complaint, during the
routine post-operative care intervals.
The highest score of the repeated
assessments was recorded.
Both scales were approved by a
panel of experts.

acorn.org.au
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Sample size
The literature indicated the average
incidence for PONV is around
30 per cent of patients. We aimed
to reduce this by 50 per cent. For
the power analysis, alpha was set
at 0.05 and estimated power at
0.8. Estimated effect size of two
independent groups was calculated
at an average of 0.5 (d=0.50). 24 In
consideration of any data loss and
non-parametric analysis, the power
analysis determined the sample size
at a minimum of 140 participants –
70 laparoscopic cholecystectomy
participants (35 in each of the
intervention and control groups) and
70 thyroidectomy participants (35 in
each of the intervention and control
groups).

Simple stratified
randomisation
The patients were assigned to
the four groups – laparoscopic
cholecystectomy control and
intervention and thyroidectomy
control and intervention – by simple
randomisation using an online
number randomisation service.45
The primary investigator gave
consecutive registration numbers
to volunteering participants;
these registration numbers were
randomised and used to assign
participants to a group (intervention
or control). Allocation was marked
only on the data collection forms,
the patient records did not include
any allocation information.

Partial blinding
This study was an open-label RCT.
The outcome measures of the
intervention were not disclosed to
participants – information provided
to participants included the general
statement ‘gastrointestinal system
and other post-operative outcomes
will be observed after surgery’. The
nurses who collected the post-
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operative data were blinded to the
group allocation of participants. The
external expert who supervised the
statistical analysis was not blinded
to the group allocations.

Statistical analysis
Statistical analyses were performed
with SPSS 21.0 (IBM Corp. released
2012, Armonk, NY, USA) package
program. Descriptive statistics were
mean, standard deviation, median,
minimum–maximum, frequency,
percentile and regression analysis.
We used Pearson’s chi-squared
test and Fisher’s exact test in the
comparison of discrete variables
regarding the incidence of PONV.
We performed Mann Whitney U test
for comparisons between groups of
continuous variables related to the
severity of PONV with mean scores
of the R-INVR and the NRS. P <0.05
value was accepted for statistical
significance with a 95 per cent
confidence interval.

Ethical considerations
Following the institutional permits
and ethical approval from Istanbul
University, Cerrahpaşa Medical
Faculty Ethical Board (03/05/2017166977), health professionals in the
relevant departments were informed.
The primary investigator approached
the patients at their pre-operative
anaesthesia examination a few days
before their surgery, provided verbal
and written information about the
study, and obtained written consent
from voluntary participants.
We censored the patient
identification information in the data
set prior to the analyses, archived
all patient data collection forms
safely, and stored and protected the
electronic data in an offline device.

Results
The study was conducted with a
total of 142 participants in four
groups; 72 of the participants
underwent thyroidectomy – 37 were
randomly assigned to the control
group (T-control) and 35 to the
intervention group (T-intervention);
70 patients underwent laparoscopic
cholecystectomy – 37 were randomly
assigned to the control group (LCcontrol) and 33 to the intervention
group (LC-intervention). Table 1
shows the distribution of variables of
the four groups.
The intervention and control groups
were comparable in terms of type
of surgery, age, gender, smoking
status, PONV or motion sickness
history and obesity. On the other
hand, more participants in the
intervention group had a history
of gastric morbidity (presence
of ulcer, gastritis, reflux, hiatus
hernia, pain or gastric cancer), In
addition, more patients received
tramadol hydrochloride in the
intervention groups of both types
of surgery, and more patients in
the thyroidectomy control group
received dexamethasone compared
to the intervention group.
Four of Koivuranta’s five PONV risk
factors 38 – being female, being
younger than 50, being a non-smoker
(tobacco) and having a history of
PONV and/or motion sickness were
included in the data collection to
facilitate comparisons to results
in future studies. Other PONV risk
factors indicated in the literature,
including opioid, antiemetic,
or tramadol hydrochloride
administration (opioid analgesic),
and body mass index 1 (recorded as
obesity) were included for the same
reasons.
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Assessment (n=220)
Excluded (n=72)
• not meeting the inclusion
criteria (n=33)

Enrolment

• declined to participate
(n=18)
Did not receive intervention
(n=2)

Randomisation (n=148)

• postponed operation
(n=2)

• postponed operation
(n=21)

Allocation

Received intervention (n=72)

Received standard care (n=74)

• thyroidectomy participants (n=37)

• thyroidectomy participants (n=37)

• laparoscopic cholecystectomy
participants (n=35)

• laparoscopic cholecystectomy
participants (n=37)

Thyroidectomy participants lost to
follow-up (n=2)
• missing data (n=2)
Laparoscopic cholecystectomy
participants lost to follow-up (n=2)
• missing data (n=1)
• left the study (n=1)

Follow-up (n=142)

Followed up (n=68)

Followed up (n=74)

Thyroidectomy participants (n=35)

Thyroidectomy participants (n=37)

Laparoscopic cholecystectomy participants
(n=33)

Laparoscopic cholecystectomy participants
(n=37)

Analysis (n=142)

Analysed (n=68)

Analysed (n=74)

• Thyroidectomy participants (n=35)

• Thyroidectomy participants (n=37)

• Laparoscopic cholecystectomy
participants (n=33)

• Laparoscopic cholecystectomy
participants (n=37)

Figure 2: Modified Consolidated Standards of Reporting Trials (CONSORT) flow diagram for individual randomised
controlled trials of nonpharmacologic treatments
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Table 1: Distribution of variables between groups (N=142)
Control
(n=74)

Intervention
(n=68)

Thyroidectomy

37 (50.0%)

35 (51.5%)

Laparoscopic
cholecystectomy

37 (50.0%)

33 (48.5%)

Female

63 (85.1%)

52 (76.5%)

Male

11 (14.9%)

16 (23.5%)

47.1±14.4

45.7±12.3

50.5 (19–79)

45 (22–79)

Smoking

16 (21.6%)

19 (27.9%)

Non-smoking

58 (78.4%)

49 (72.1%)

No

60 (81.1%)

53 (77.9%)

Yes

14 (18.9%)

15 (22.1%)

No

47 (63.5%)

52 (76.5%)

Yes

27 (36.5%)

16 (23.5%)

No

47 (63.5%)

32 (47.1%)

Yes

27 (36.5%)

36 (52.9%)

No

67 (90.5%)

48 (70.6%)

Yes

7 (9.5%)

20 (29.4%)

16 (43.2%)

6 (17.1%)

1 (2.7%)

3 (9.1%)

Variable
Operation

Gender∝

Age∝

Smoking status ∝
History of PONV
and motion
sickness ∝*
Obesity
Gastric
morbidity
Use of tramadol
hydrochloride
Use of
dexamethasone

Mean ± standard deviation
Median (min–max)

Thyroidectomy
Laparoscopic
cholecystectomy

PONV = Post-operative nausea and vomiting; ∝ = Koivuranta risk factor; Gastric
morbidity = presence of ulcer, gastritis, reflux, hiatus hernia, pain or gastric cancer
* All participants who had a history of PONV also had a history of motion sickness.

The time between the intervention
(ingestion of honey and water
mixture) and anaesthesia induction
varied from two to five hours, as the
daily operation lists were frequently
updated; however, the difference
in incidence of PONV was not
significant (Spearmen’s correlation
-0.085, P=0.49).
Table 2 shows the incidence of
PONV in the four groups. There
was no significant difference in
incidence of PONV in the R-INVR
mean score comparison between
the thyroidectomy groups (Pearson
χ2 =0.038; p=0.84; df=1). However,
a statistically significant lower
severity of PONV was determined in
the laparoscopic cholecystectomy
intervention group than in the
control group (Pearson χ2 =4.54;
p=0.03; df=1).
Table 3 shows the mean R-INVR
and NRS scores for each group.
The R-INVR and NRS scores were
statistically lower in the laparoscopic
cholecystectomy intervention
group than in the control group;
no statistical significance was
calculated between thyroidectomy
intervention and control groups
(Table 3).

Discussion
The intervention and control groups
in the present study had a similar
distribution of characteristics,
including the PONV risk factors
(gender, age, smoking status and

Table 2: Incidence of PONV by R-INVR (N=142)
Operation
Thyroidectomy
Laparoscopic
cholecystectomy

R-INVR Score

Control n

Intervention n

0

30 (81.1%)

29 (82.9%)

>0

7 (18.9%)

6 (17.1%)

0

23 (62.2%)

28 (84.8%)

>0

14 (37.8%)

5 (15.2%)

Pearson χ2 / df

P*

0.038 / 1

0.84

4.54 / 1

0.03

R-INVR = Rhodes index of nausea, vomiting and retching (8 items of 0–4 points, total of 0–32 points); df = degrees of freedom
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Table 3: Mean R-INVR and NRS scores (N=142)

Score

Operation
Thyroidectomy

R-INVR

Laparoscopic
cholecystectomy
Thyroidectomy

NRS

Laparoscopic
cholecystectomy

Group

n

Mean±SD

Median
(min–max)

Control

37

1.8±4.3

0 (0-17)

Intervention

35

1.6±5.4

0 (0-30)

Control

37

3.0±5.1

0 (0-23)

Intervention

33

0.5±1.4

0 (0-6)

Control

37

1.1±2.5

0 (0-8)

Intervention

35

1.1±2.4

0 (0-10)

Control

37

2.0±2.7

0 (0-7)

Intervention

33

0.4±1.4

0 (0-5)

MannWhitney U

P

629.5

0.76

446.5

0.01

629.5

0.95

444.5

0.01

R-INVR = Rhodes index of nausea, vomiting and retching (8 items of 0–4 points, total of 0–32 points);
NRS = numeric rating scale (0–10)

history of PONV or motion sickness).
The time between the intervention
(ingestion of honey and water
mixture) and anaesthesia induction
varied from two to five hours, as the
daily operation lists were frequently
updated; however, the difference
between PONV incidence and mean
R_INVR was not significant. The
incidence of PONV was significantly
lower in the laparoscopic
cholecystectomy intervention group;
there was no significant difference
between the thyroidectomy groups.
In line with the literature, 5,38,46,47 we
believe the balanced distribution
of factors affecting PONV among
the groups strengthens the results
of our study. Gastric morbidity can
make a patient more prone to PONV48
and history of gastric morbidity was
more frequent in the intervention
groups for both surgeries. Therefore,
we considered the lower incidence of
PONV to be another strength for the
validity of the results.
Oral pre-operative carbohydrate
solutions have been shown to be
effective in reducing PONV in some
studies. Yilmaz et al. 34 and Ayoğlu et
al. 24 showed in their research that
200 kilocalories of carbohydrate

and 400 ml of fluid administered
to participants two hours before
laparoscopic cholecystectomy
surgery reduced early PONV, Weledji
et al. 35 showed positive effects of
pre-operative oral carbohydrate
intake on metabolic and endocrine
surgical stress response and an RCT
by Hausel et al. 21 showed that preoperative carbohydrate solutions
could reduce PONV.16 In contrast,
Poyraz49 examined the effects of
pre-operative oral carbohydrate
solutions on surgical stress response
and did not find any significant
difference. A number of systematic
reviews and guidelines stated the
need for more robust RCTs that
include an anaesthesia protocol,
antiemetic treatment and rescue
treatment. 2,50,51
We observed a significantly
lower occurrence of PONV in the
intervention group compared to
the control group of laparoscopic
cholecystectomy participants.
In thyroidectomy participants,
significantly more patients
received dexamethasone in
the control group to prevent
vocal cord oedema. The lack of
significant differences between
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the thyroidectomy groups may be
associated with the antiemetic effect
of dexamethasone. 52,53 Lauwick et
al. 54 also reported no difference
in PONV with oral carbohydrate
administration with thyroidectomy
participants. They indicated that
factors such as pharynx and vagal
nerve stimulation may have affected
their results and that a more
detailed examination was necessary
to draw conclusions. 54
Post-operative nausea and vomiting
is one of the most common
perioperative complications, and
pre-operative oral carbohydrate
administration is recommended
for its prevention. Honey is a
natural and available source of
carbohydrate. Pre-operative oral
honey and water administration can
reduce the incidence and severity of
PONV.
In-service or postgraduate education
programs for perioperative health
professionals could include up-todate recommendations for improved
patient care, such as ERAS protocols
which involve reducing pre-operative
fasting time and providing preoperative oral carbohydrates.
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Anaesthetists, surgeons and
perioperative nurses should be
informed of the consequences of
prolonged fasting practices and
recent evidence regarding the safety
of pre-operative oral intake. Studies
have shown no changes in gastric
emptying time between individuals
(including patients with obesity or
diabetes, unless gastric reflux was
present) or any risk of aspiration for
fluids ingested up until two hours
prior to surgery. These findings
from oral carbohydrate loading
were equal to overnight fasting.1,55
The recommendations for all solid
and liquid dietary intake have
been present for quite some years;
however, today’s routine surgical
practices still do not reflect those
recommendations.
Despite the fact that general
anaesthesia practices have been
trending towards the reduction
of volatile anaesthetics to reduce
PONV, the issue seems to remain
pertinent. Therefore, further
studies to modify risk factors and
reduce the incidence of PONV are
recommended. Considering that
the results for thyroidectomy
participants in our study were not
significant, covariate-adaptive
randomisation is recommended in
future studies to obtain definitive
evidence for this type of surgery
and the relation between the use of
dexamethasone and PONV.

Strengths and limitations
The R-INVR and NRS scales used
in this study to measure outcomes
and to define risk for PONV were
previously validated, and the
sample size was sufficient. Data
was presented regarding the type
and total dose of medications that
impact emesis, such as anaesthetics,
antiemetics, tramadol-HCl and
dexamethasone. This will assist
with replication of the study and
applicability of the results. However,

e-30

PONV incidence in total intravenous
anaesthesia should be further
investigated as our study included
combined inhalation and intravenous
anaesthesia protocols.
Identified limitations are that the
study was conducted in a single
centre, and the primary investigator
registered the participants and
conducted randomised allocation.
A potential bias could exist during
the study’s introduction; however,
we prevented this by providing the
same information to all participants
and blinding the nurses collecting
the data to the group allocation.
The interrater reliability for the
nurses’ collection of the data was
not analysed and this could present
another limitation.
The use of dexamethasone and
antiemetic treatment, tramadol
hydrochloride, could not be
standardised across groups. The
total doses of each medication
administered were analysed,
and no influence on the primary
outcomes was determined. The time
between intervention (participants
ingesting the honey and water mix)
and anaesthesia induction also
varied between participants, as
the operation list of the day was
frequently updated. The amount
of time from the intervention to
anaesthesia induction varied from
two hours to five hours, and this was
analysed against PONV outcomes
using regression analysis; however,
the difference appeared not to be
statistically significant.

Conclusion
In this RCT, it was discovered that
honey could be recommended
as a simple and inexpensive preoperative oral carbohydrate to
prevent or reduce PONV in adult
participants receiving general
anaesthesia (combined inhalation
and intravenous administration)

undergoing laparoscopic
cholecystectomy. Honey, which
is a common and economical
nutrient, is available as an effective
intervention for PONV prevention
and is an alternative to commercially
prepared, processed carbohydrate
which is less economical.

Knowledge translation
• PONV is presently one of the
most common perioperative
complications. Pre-operative
oral carbohydrate administration
is recommended for PONV
prevention.
• Honey is a natural, economical
and readily available source of
carbohydrate. Pre-operative oral
honey and water administration
can reduce the incidence and the
severity of PONV in laparoscopic
cholecystectomy.
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